Unveiling the intricacies of COVID ‐19: Autoimmunity, multi‐organ manifestations and the role of autoantibodies
Scandinavian Journal of Immunology · 2024-02 · 99 (2)
DOI: 10.1111/sji.13344 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 10.12.2023. Verfasst von Zetao Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: COVID-19, Autoantibodies, SARS-CoV-2, Autoimmunity. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 135 Literaturangaben. Gefördert von: Shanghai Gaofeng & Gaoyuan Project for University Academic Program Development, Innovative Research Team of High-level Local Universities in Shanghai, National Natural Science Foundation of China.
Abstract (Originalsprache)
COVID‐19 is a severe infectious disease caused by a SARS‐CoV‐2 infection. It has caused a global pandemic and can lead to acute respiratory distress syndrome (ARDS). Beyond the respiratory system, the disease manifests in multiple organs, producing a spectrum of clinical symptoms. A pivotal factor in the disease's progression is autoimmunity, which intensifies its severity and contributes to multi‐organ injuries. The intricate interaction between the virus' spike protein and human proteins may engender the generation of autoreactive antibodies through molecular mimicry. This can further convolute the immune response, with the potential to escalate into overt autoimmunity. There is also emerging evidence to suggest that COVID‐19 vaccinations might elicit analogous autoimmune responses. Advanced technologies have pinpointed self‐reactive antibodies that target diverse organs or immune‐modulatory proteins. The interplay between autoantibody levels and multi‐organ manifestations underscores the importance of regular monitoring of serum antibodies and proinflammatory markers. A combination of immunosuppressive treatments and antiviral therapy is crucial for managing COVID‐19‐associated autoimmune diseases. The review will focus on the generation of autoantibodies in the context of COVID‐19 and their impact on organ health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Exercise and Health, Shanghai University of Sport, Shanghai, China.
- School of Athletic Performance, Shanghai University of Sport, Shanghai, China.
ORCID-Profile: Yue Shi
Förderung
- Shanghai Gaofeng & Gaoyuan Project for University Academic Program Development
- Innovative Research Team of High-level Local Universities in Shanghai
- National Natural Science Foundation of China
- Shanghai Key Lab of Human Performance
- Shanghai Sailing Program
Zitieren
APA
Ding, Z., Wei, X., Pan, H., Shi, H., & Shi, Y. (2024). Unveiling the intricacies of COVID ‐19: Autoimmunity, multi‐organ manifestations and the role of autoantibodies. Scandinavian Journal of Immunology, 99(2). https://doi.org/10.1111/sji.13344
Vancouver
Ding Z, Wei X, Pan H, Shi H, Shi Y. Unveiling the intricacies of COVID ‐19: Autoimmunity, multi‐organ manifestations and the role of autoantibodies. Scandinavian Journal of Immunology. 2024;99(2). doi:10.1111/sji.13344
BibTeX
@article{Ding2024,
author = {Ding, Zetao and Wei, Xingyi and Pan, Haoyu and Shi, Hui and Shi, Yue},
title = {Unveiling the intricacies of COVID ‐19: Autoimmunity, multi‐organ manifestations and the role of autoantibodies},
journal = {Scandinavian Journal of Immunology},
year = {2024},
volume = {99},
number = {2},
doi = {10.1111/sji.13344}
}
EUVIMED